Literature DB >> 2193615

Plasmid-mediated 4-quinolone resistance: a real or apparent absence?

P Courvalin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2193615      PMCID： PMC171673          DOI： 10.1128/AAC.34.5.681

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  18 in total

1.  Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus.

Authors:  K Ubukata; N Itoh-Yamashita; M Konno
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Occurrence of the Campylobacter resistance gene tetO in Enterococcus and Streptococcus spp.

Authors:  R Zilhao; B Papadopoulou; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

3.  Inhibition of R-plasmid transfer in Escherichia coli by 4-quinolones.

Authors:  J Weisser; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

4.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.

Authors:  R Leclercq; E Derlot; J Duval; P Courvalin
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

5.  Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.

Authors:  S P Cohen; L M McMurry; D C Hooper; J S Wolfson; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

6.  Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.

Authors:  K Hirai; H Aoyama; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

7.  Bacterial conjugative plasmids mobilize DNA transfer between bacteria and yeast.

Authors:  J A Heinemann; G F Sprague
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

8.  Quinolone-resistant mutations of the gyrA gene of Escherichia coli.

Authors:  H Yoshida; T Kojima; J Yamagishi; S Nakamura
Journal:  Mol Gen Genet       Date:  1988-01

9.  Evidence for natural gene transfer from gram-positive cocci to Escherichia coli.

Authors:  A Brisson-Noël; M Arthur; P Courvalin
Journal:  J Bacteriol       Date:  1988-04       Impact factor: 3.490

10.  Transferable 5-nitroimidazole resistance in the Bacteroides fragilis group.

Authors:  J Breuil; A Dublanchet; N Truffaut; M Sebald
Journal:  Plasmid       Date:  1989-03       Impact factor: 3.466
View more
  28 in total

Review 1.  In vitro antibacterial activity and pharmacodynamics of new quinolones.

Authors:  A Dalhoff; F-J Schmitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-04-01       Impact factor: 3.267

2.  Mechanisms of reduced susceptibility to ciprofloxacin in Escherichia coli isolates from Canadian hospitals.

Authors:  Patricia J Baudry-Simner; Amanpreet Singh; James A Karlowsky; Daryl J Hoban; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

3.  Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.

Authors:  John H Tran; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 4.  Discovery and development of new antibiotics: the problem of antibiotic resistance.

Authors:  L L Silver; K A Bostian
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

5.  Beta-lactam resistance in aerobic faecal flora from general practice patients in the UK.

Authors:  P M Shanahan; C J Thomson; S G Amyes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

Review 6.  Ofloxacin clinical pharmacokinetics.

Authors:  K C Lamp; E M Bailey; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 7.  Use of the quinolones in paediatrics.

Authors:  U B Schaad
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 8.  Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance.

Authors:  David C Hooper; George A Jacoby
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

Review 9.  Lomefloxacin clinical pharmacokinetics.

Authors:  C D Freeman; D P Nicolau; P P Belliveau; C H Nightingale
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

10.  Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers.

Authors:  M Oethinger; S Conrad; K Kaifel; A Cometta; J Bille; G Klotz; M P Glauser; R Marre; W V Kern
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.